ofloxacin has been researched along with ambroxol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Bouvet, O; Bressolle, F; Chanez, P; Fabre, D; Galtier, M; Godard, P; Michel, FB; Paganin, F | 1 |
| Datau, EA | 1 |
1 trial(s) available for ofloxacin and ambroxol
| Article | Year |
|---|---|
Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.
Topics: Administration, Oral; Aged; Ambroxol; Anti-Infective Agents; Biopsy; Bronchi; Bronchoscopy; Chromatography, High Pressure Liquid; Expectorants; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Ofloxacin; Streptococcus pneumoniae; Tissue Distribution | 1995 |
3 other study(ies) available for ofloxacin and ambroxol
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Candida albicans; Candidiasis; Ethanolamines; Expectorants; Fluconazole; Formoterol Fumarate; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Ofloxacin | 2012 |